Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Diabetes|January 30, 2004
Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db miceYin Liang, Melville C Osborne, Brett P Monia, et al.Journal of Medicinal Chemistry|December 30, 2003
Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes modelPhilip J Rybczynski, Roxanne E Zeck, Joseph Dudash, et al.International Journal of Clinical Pharmacology and Therapeutics|May 15, 2012
Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humansTroy C Sarich, Margery A Connelly, Dorota B Schranz, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonistsMin Amy Xiang, Robert H Chen, Keith T Demarest, et al.Bioorganic & Medicinal Chemistry Letters|December 29, 2005
Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2Xiaoyan Zhang, Maud Urbanski, Mona Patel, et al.Bioorganic & Medicinal Chemistry Letters|October 4, 2005
Heteroaryl-O-glucosides as novel sodium glucose co-transporter 2 inhibitors. Part 1Xiaoyan Zhang, Maud Urbanski, Mona Patel, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Design and synthesis of indane-ureido-thioisobutyric acids: A novel class of PPARalpha agonistsJay M Matthews, Xiaoli Chen, Ellen Cryan, et al.Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activityAlexey B Dyatkin, William J Hoekstra, Dennis J Hlasta, et al.Journal of Medicinal Chemistry|May 16, 2007
Synthesis and biological evaluation of 3-aryl-3-(4-phenoxy)-propionic acid as a novel series of G protein-coupled receptor 40 agonistsFengbin Song, Songfeng Lu, Joe Gunnet, et al.Bioorganic & Medicinal Chemistry|May 26, 2004
Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitorsDavid J O'Neill, Lan Shen, Catherine Prouty, et al.Pageof 5